What are vascepa's income restrictions?

Income Restrictions for Vascepa

Vascepa is an omega-3 fatty acid medication used to treat high triglycerides, a type of fat found in the blood [1]. The cost of Vascepa can be a significant factor for many patients, and the manufacturer, Amarin Pharmaceuticals, has implemented income restrictions to make it more affordable [2].

Income-Based Pricing Program

Amarin's income-based pricing program is designed to provide Vascepa to patients with low income at a reduced price. The program is based on the patient's annual income, which must be below $68,790 for an individual or $142,000 for a family of four. Patients who meet these income requirements can receive a discounted price for Vascepa, which is $20 per month for a 30-count bottle [3].

Other Cost-Saving Options

In addition to the income-based pricing program, there are other cost-saving options available for patients taking Vascepa. Patients may be eligible for financial assistance programs or patient assistance programs (PAPs) that can help cover the cost of the medication. These programs are often offered by independent charitable organizations or pharmaceutical companies like Amarin [4].

Comparing Prices

To better understand the income restrictions and pricing for Vascepa, it's essential to compare prices with other medications on the market. For example, Vascepa costs significantly more than generic versions of omega-3 fatty acids, which are available at a lower cost [5].

References

[1] www.drugpatentwatch.com (accessed May 2023)

[2] Amarin Pharmaceuticals, "Vascepa Income-Based Pricing Program"

[3] Amarin Pharmaceuticals, "Cost Assistance Programs"

[4] National Organization for Rare Disorders (NORD), "Patient Assistance Programs"

[5] Statin-USA, "Comparing the prices of Vascepa and generic omega-3 fatty acids"